Literature DB >> 12888190

Attention deficit hyperactivity disorder: guidelines for investigating efficacy of pharmacological intervention.

J K Buitelaar, S A Montgomery, B J van Zwieten-Boot.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12888190     DOI： 10.1016/s0924-977x(03)00047-6

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN： 0924-977X            Impact factor:   4.600


× No keyword cloud information.
  8 in total

1.  Increased intra-individual reaction time variability in attention-deficit/hyperactivity disorder across response inhibition tasks with different cognitive demands.

Authors:  Rebecca G Vaurio; Daniel J Simmonds; Stewart H Mostofsky
Journal:  Neuropsychologia       Date:  2009-01-22       Impact factor: 3.139

2.  Post Hoc Analysis of Potential Predictors of Response to Atomoxetine for the Treatment of Adults with Attention-Deficit/Hyperactivity Disorder using an Integrated Database.

Authors:  Chris Bushe; Esther Sobanski; David Coghill; Lovisa Berggren; Katrien De Bruyckere; Sami Leppämäki
Journal:  CNS Drugs       Date:  2016-04       Impact factor: 5.749

Review 3.  Lisdexamfetamine.

Authors:  Stephanie K A Blick; Gillian M Keating
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

4.  ADORE -- Attention-Deficit Hyperactivity Disorder Observational Research in Europe.

Authors:  Stephen J Ralston; Maria J M Lorenzo
Journal:  Eur Child Adolesc Psychiatry       Date:  2004       Impact factor: 4.785

5.  Telepsychiatrists' Medication Treatment Strategies in the Children's Attention-Deficit/Hyperactivity Disorder Telemental Health Treatment Study.

Authors:  Carol M Rockhill; Yuet Juhn Tse; Megan D Fesinmeyer; Jessica Garcia; Kathleen Myers
Journal:  J Child Adolesc Psychopharmacol       Date:  2015-08-10       Impact factor: 2.576

6.  Effect of Pycnogenol® on attention-deficit hyperactivity disorder (ADHD): study protocol for a randomised controlled trial.

Authors:  Annelies A J Verlaet; Berten Ceulemans; Helene Verhelst; Dirk Van West; Tess De Bruyne; Luc Pieters; Huub F J Savelkoul; Nina Hermans
Journal:  Trials       Date:  2017-03-28       Impact factor: 2.279

7.  Efficacy and Safety of Polyunsaturated Fatty Acids Supplementation in the Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Children and Adolescents: A Systematic Review and Meta-Analysis of Clinical Trials.

Authors:  Mina Nicole Händel; Jeanett Friis Rohde; Marie Louise Rimestad; Elisabeth Bandak; Kirsten Birkefoss; Britta Tendal; Sanne Lemcke; Henriette Edemann Callesen
Journal:  Nutrients       Date:  2021-04-08       Impact factor: 5.717

8.  A Phase 3, Placebo-Controlled Trial of Once-Daily Viloxazine Extended-Release Capsules in Adolescents With Attention-Deficit/Hyperactivity Disorder.

Authors:  Azmi Nasser; Tesfaye Liranso; Toyin Adewole; Nicholas Fry; Joseph T Hull; Gregory D Busse; Fatima Chowdhry; Andrew J Cutler; Nandita Joshi Jones; Robert L Findling; Stefan Schwabe
Journal:  J Clin Psychopharmacol       Date:  2021 Jul-Aug 01       Impact factor: 3.153
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.